These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28689967)

  • 1. Cyclodextrin-Modified inorganic materials for the construction of nanocarriers.
    Cutrone G; Casas-Solvas JM; Vargas-Berenguel A
    Int J Pharm; 2017 Oct; 531(2):621-639. PubMed ID: 28689967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review.
    Mura P
    Int J Pharm; 2020 Apr; 579():119181. PubMed ID: 32112928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs.
    Li J; Wang Y; Xue S; Sun J; Zhang W; Hu P; Ji L; Mao Z
    Int J Nanomedicine; 2016; 11():4609-4624. PubMed ID: 27695321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of Native Cyclodextrins with Metal Ions and Inorganic Nanoparticles: Fertile Landscape for Chemistry and Materials Science.
    Prochowicz D; Kornowicz A; Lewiński J
    Chem Rev; 2017 Nov; 117(22):13461-13501. PubMed ID: 29048880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Encapsulated Cyclodextrin Nanosponges.
    Tannous M; Caldera F; Hoti G; Dianzani U; Cavalli R; Trotta F
    Methods Mol Biol; 2021; 2207():247-283. PubMed ID: 33113141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrin based nanosponges for pharmaceutical use: a review.
    Tejashri G; Amrita B; Darshana J
    Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications.
    Zafar N; Fessi H; Elaissari A
    Int J Pharm; 2014 Jan; 461(1-2):351-66. PubMed ID: 24342710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular encapsulator on the surface of magnetic nanoparticles. Controlled drug release from calcium Ferrite/Cyclodextrin-tethered polymer hybrid.
    Ramasamy S; Samathanam B; Reuther H; Adyanpuram MNMS; Enoch IVMV; Potzger K
    Colloids Surf B Biointerfaces; 2018 Jan; 161():347-355. PubMed ID: 29100128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics.
    Liang R; Wei M; Evans DG; Duan X
    Chem Commun (Camb); 2014 Nov; 50(91):14071-81. PubMed ID: 24955443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic cyclodextrin nanoparticles.
    Varan G; Varan C; Erdoğar N; Hıncal AA; Bilensoy E
    Int J Pharm; 2017 Oct; 531(2):457-469. PubMed ID: 28596142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles.
    Bilensoy E; Hincal AA
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1161-73. PubMed ID: 19705965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles.
    Nehilla BJ; Allen PG; Desai TA
    ACS Nano; 2008 Mar; 2(3):538-44. PubMed ID: 19206580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents.
    Liu Y; Mi Y; Zhao J; Feng SS
    Int J Pharm; 2011 Dec; 421(2):370-8. PubMed ID: 22001536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of nanosponges to cancer drug delivery.
    Trotta F; Dianzani C; Caldera F; Mognetti B; Cavalli R
    Expert Opin Drug Deliv; 2014 Jun; 11(6):931-41. PubMed ID: 24811423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
    Lakkakula JR; Maçedo Krause RW
    Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
    Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
    Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible crosslinked β-cyclodextrin nanoparticles as multifunctional carriers for cellular delivery.
    Datz S; Illes B; Gößl D; Schirnding CV; Engelke H; Bein T
    Nanoscale; 2018 Aug; 10(34):16284-16292. PubMed ID: 30128442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
    Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I
    J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin Nanoparticles Bearing 8-Hydroxyquinoline Ligands as Multifunctional Biomaterials.
    Oliveri V; Bellia F; Vecchio G
    Chemistry; 2017 Mar; 23(18):4442-4449. PubMed ID: 28150894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.